NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-007-2014-0-FR-06 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE FR EP 14805427.3 Abandoned
NCI E-007-2014-0-DE-05 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE DE EP 14805427.3 Abandoned
NCI E-007-2014-0-EP-03 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE EP National Stage 14805427.3 Abandoned
NCI E-007-2014-0-PCT-02 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE PCT PCT PCT/US2014/064383 Expired
NIAID E-214-2015-0-JP-07 Conformationally Specific Viral Immunogens JP National Stage 2015-511675 Abandoned
NCI E-261-2016-0-US-01 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer US 62/075,936 Abandoned
NCI E-750-2013-0-CA-04 Method for Subtyping Lymphoma Types by Means of Expression Profiling CA National Stage 2929826 Issued
NCI E-750-2013-0-AU-03 Method for Subtyping Lymphoma Types by Means of Expression Profiling AU National Stage 2014346788 Issued
NCI E-750-2013-0-FR-15 Methods for Subtyping Lymphoma Types by Means of Expression Profiling FR EP 14803288.1 Issued
NCI E-750-2013-0-DE-13 Methods for Subtyping Lymphoma Types by Means of Expression Profiling DE EP 14803288.1 Issued
NCI E-750-2013-0-IT-18 Methods for Subtyping Lymphoma Types by Means of Expression Profiling IT EP 14803288.1 Issued
NCI E-750-2013-0-IE-17 Methods for Subtyping Lymphoma Types by Means of Expression Profiling IE EP 14803288.1 Issued
NCI E-750-2013-0-GB-16 Methods for Subtyping Lymphoma Types by Means of Expression Profiling GB EP 14803288.1 Issued
NCI E-750-2013-0-CH-12 Methods for Subtyping Lymphoma Types by Means of Expression Profiling CH EP 14803288.1 Issued
NCI E-750-2013-0-ES-14 Methods for Subtyping Lymphoma Types by Means of Expression Profiling ES EP 14803288.1 Issued
NCI E-750-2013-0-EP-06 Methods for Subtyping Lymphoma Types by Means of Expression Profiling EP National Stage 14803288.1 Issued
NCI E-040-2012-0-RU-19 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU National Stage 2014144143 Issued
NCI E-271-2014-0-PCT-01 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof PCT PCT PCT/US2014/064136 Expired
NCI E-750-2013-0-PCT-02 Methods for Subtyping Lymphoma Types by Means of Expression Profiling PCT PCT PCT/US2014/064161 Expired
NHLBI E-166-2014-0-US-01 T CELLS AND DENDRITIC CELLS FOR POLYOMAVIRUS THERAPY US 62/075,726 Abandoned
NCI E-117-2011-0-ZA-21 Recombinant Immunotoxin Targeting Mesothelin ZA National Stage 2013/08270 Abandoned
NIEHS E-080-2012-0-US-05 USES OF ANTAGONISTS OF HYALURONAN SIGNALING US National Stage 14/398,837 9717752 Issued PDF
NCATS E-072-2012-0-US-04 Modulators Of The Relaxin Receptor 1 US National Stage 14/398,830 9452973 Issued PDF
NCI E-044-2003-0-US-07 Compositions Comprising Nucleic Acids Encoding HIV-1 Reverse Transcriptase CTL Epitopes US DIV 14/531,540 Abandoned
NCI E-008-2014-2-CA-02 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same CA National Stage 2932424 Issued
NCI E-008-2014-2-SG-06 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same SG National Stage 11201604565W Issued
NCI E-008-2014-2-CN-03 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same CN National Stage 201480072437.4 Issued
NCI E-008-2014-2-JP-09 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same JP National Stage 2016-536812 Issued
NCI E-008-2014-2-US-08 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same US National Stage 15/101,583 10676528 Issued PDF
NCI E-008-2014-2-RU-05 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same RU National Stage 2016124670 Abandoned
NCI E-008-2014-2-GB-13 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same GB EP 14802259.3 Issued
NCI E-008-2014-2-FR-12 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same FR EP 14802259.3 Issued
NCI E-008-2014-2-DE-11 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same DE EP 14802259.3 Issued
NCI E-008-2014-2-EP-04 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same EP National Stage 14802259.3 Issued
NIAAA E-070-2012-0-FR-06 Derivatives of Docosahexaenoylethanolamide and Uses Thereof FR EP 13714787.2 Issued
NIAAA E-070-2012-0-DE-05 Derivatives of Docosahexaenoylethanolamide and Uses Thereof DE EP 13714787.2 Issued
NIAAA E-070-2012-0-GB-07 Derivatives of Docosahexaenoylethanolamide and Uses Thereof GB EP 13714787.2 Issued
NCI E-232-2009-0-AU-07 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System AU DIV 2014256364 Abandoned
NCI E-008-2014-2-PCT-01 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same PCT PCT COMB PCT/US2014/063096 Expired
NCI E-141-2008-0-HK-27 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof HK National Stage 14110833.4 Abandoned
NICHD E-001-2007-0-US-09 Conjugates of Plasmodium Falciparum Surface Proteins As Malaria Vaccines US DIV 14/527,676 Abandoned
NCI E-141-2008-0-HK-26 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof HK National Stage 14110832.5 Abandoned
NIBIB E-247-2014-0-US-01 Systems and Methods for Distinguishing Stimulated Emission As A Means Of Increasing The Signal Of Fluorescence Microscopy US 62/072,218 Abandoned
NCI E-188-2010-1-US-02 Human Monoclonal Antibody Against Human Folate Receptor Beta US CON 14/524,304 9914773 Issued PDF
NCI E-230-2011-1-US-05 Vascular Endothelial Growth Factor Antagonists And Methods For Their Use US National Stage 14/397,435 9550818 Issued PDF
NHLBI E-018-2014-0-PCT-02 Atrial Appendage Ligation PCT PCT PCT/US2014/062364 Expired
NHLBI E-018-2014-0-EP-03 Atrial Appendage Ligation EP National Stage 14855406.6 Abandoned
NCI E-294-2011-0-US-05 Use Of CpG Oligonucleotides Co-formulated With an Antibiotic To Accelerate Wound Healing US National Stage 14/397,156 10076535 Issued PDF
NEI E-036-2012-0-JP-06 Methods of Producing and Using Regulatory B-Cells JP National Stage 2015-509008 Issued
NIDCR E-109-2000-0-US-06 Selective Ablation of Pain-Sensing Neurons By Administration of A Vanilloid Receptor Agonist US DIV 14/523,752 9827223 Expired PDF